Ind-Swift Laboratories Limited
Overview
Ind-Swift Laboratories Limited is a leading pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs). It is known for its strong presence in the generic drug market.
Core services & business areas
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Ind-Swift Laboratories Limited is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Ind-Swift Laboratories Limited holds 0 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- DUTASTERIDE USPInactive2014-06-13
- COLESEVELAM HYDROCHLORIDEInactive2013-02-05
- CLOPIDOGREL CAMPHOR SULFONATEInactive2012-04-20
- CLOPIDOGREL BISULFATE USPInactive2011-02-15
- TELMISARTANInactive2011-01-05
- CLARITHROMYCIN CITRATEInactive2009-03-09
- NARATRIPTAN HYDROCHLORIDE USPInactive2008-12-26
- CLARITHROMYCIN SPECIALInactive2006-02-18
- ARIPIPRAZOLEInactive2006-02-14
- AT1 DRUG SUBSTANCE INTERMEDIATEInactive2005-09-17
- QUETIAPINE FUMARATEInactive2005-09-12
- VENLAFAXINE HYDROCHLORIDEInactive2005-03-01
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Ind-Swift Laboratories Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Ind-Swift Laboratories Limited? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.